CUAMC
MAZE

China Universal Asset Management Company’s Maze Therapeutics MAZE Stock Holding History

China Universal Asset Management Company’s Portfolio MAZE Stock Details MAZE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$412K Buy
13,808
+1,813
+15% +$47.5K 0.02% 280
2026
Q1 		$358K Buy
11,995
+554
+5% +$24.4K 0.03% 295
2025
Q4 		$474K Buy
11,441
+9,441
+472% +$324K 0.04% 263
2025
Q3 		$51.9K Buy
+2,000
New +$33.8K ﹤0.01% 429

Other funds holding MAZE

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
AC
AXQ Capital Jersey City, New Jersey $920M AUM 18.71% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

China Universal Asset Management Company's MAZE Position: Q2 2026 in Review

China Universal Asset Management Company increased its Maze Therapeutics (MAZE) stake by 15% in Q2 2026, buying an estimated $47.5K and bringing the position to 13,808 shares worth $412K. The position accounts for 0.02% of the portfolio, ranked #280.

China Universal Asset Management Company first reported a position in MAZE in Q3 2025 and has held it in 4 quarters since. The position peaked at $474K in Q4 2025. 28 funds tracked by Wall St. Rank hold MAZE as of Q2 2026.

  • China Universal Asset Management Company held 13,808 shares of Maze Therapeutics worth $412K as of Q2 2026.
  • China Universal Asset Management Company bought 1,813 Maze Therapeutics shares in Q2 2026, an estimated $47.5K.
  • Maze Therapeutics made up 0.02% of China Universal Asset Management Company's portfolio in Q2 2026, its #280 holding.
  • China Universal Asset Management Company first reported a position in Maze Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • China Universal Asset Management Company's Maze Therapeutics position peaked at $474K in Q4 2025.
  • 28 funds tracked by Wall St. Rank held Maze Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.